Rimonabant

CAS: 168273-06-1

Ref. 3D-FC61502

Product Information

• Name: Rimonabant
• Synonyms: 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide, 1-(2,4-Dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide, 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-, 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid N-(piperidin-1-yl)amide, 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide hydrochloride (1:1), A 281, Acomplia, Enp 9, N-Piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide, Rimonabant(Acomplia,Sr141716), Sr 141617, Sr 141716, Zimulti
• CAS: 168273-06-1

Description

Cannabinoid receptor 1 (CB1) antagonist. Lowers consumption of food, via central and peripheral mechanisms. Reduces triglyceride and low-density lipoprotein levels (LDLs). Reduces nicotine dependence, potentially by modulating dopaminergic signalling. Serious adverse effects associated with Rimonabant include psychiatric disorders such as anxiety and depression.

• Brand: Biosynth

Chemical properties

• Molecular weight: 463.79 g/mol
• Formula: C₂₂H₂₁Cl₃N₄O
• Color/Form: Powder
• InChI: InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)
• InChI key: InChIKey=JZCPYUJPEARBJL-UHFFFAOYSA-N
• SMILES: Cc1c(C(=O)NN2CCCCC2)nn(-c2ccc(Cl)cc2Cl)c1-c1ccc(Cl)cc1